From Name

From Email

To Name

To Email

Message

From Parkinson's to peanut allergy, pandemic puts brakes on new drugs

from The Chronicle Herald

From Parkinson's to peanut allergy, pandemic puts brakes on new drugs The Chronicle Herald Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters review of filings and interviews with executives show. The Food and Drug Administration (FDA) has approved more than 30 new medicines since January, but at least five drugmakers including Bristol Myers Squibb, Sanofi, Neurocrine Biosciences, Endo Pharmaceuticals and Aimmune have changed their launch plans. READ MORE

more